Dr Sandar Tin Tin
Sandar Tin Tin
MBBS, MPH, PhD
Girdlers’ New Zealand HRC Fellow
Sandar joined the Cancer Epidemiology Unit as a Girdlers’ New Zealand HRC (Health Research Council) Fellow in August 2019. She was trained as a medical doctor in Myanmar and holds a Master of Public Health and a PhD from the University of Auckland, New Zealand.
Sandar has a broad interest in the theoretical, methodological and applied aspects of epidemiological research, and has undertaken a number of research projects related to cancer, active travel, injury and child and youth health. Her current research is based on the UK Biobank and examines physical activity, biomarkers and breast cancer risk.
Associations between food group intakes and circulating insulin-like growth factor-I in the UK Biobank: a cross-sectional analysis.
Watling CZ. et al, (2022), Eur J Nutr
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
Scott OW. et al, (2022), Breast Cancer Res Treat, 193, 225 - 235
Metabolically-Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kliemann N. et al, (2022), Cancer Epidemiol Biomarkers Prev
Alcohol Intake and Endogenous Hormones in Pre- and Postmenopausal Women: Findings from the UK Biobank.
Tin Tin S. et al, (2021), Cancer Epidemiol Biomarkers Prev, 30, 2294 - 2301
Physical activity in relation to circulating hormone concentrations in 117,100 men in UK Biobank.
Watts EL. et al, (2021), Cancer Causes Control, 32, 1197 - 1212